4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-036036
Options or other derivatives
- Director acquired 12,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fleming Harold Edward Director | 2022-06-09 | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | D | ||
Loading xslF345X03/doc4.xml…